bf/NYSE:PFE_icon.jpeg

XETRA:PFE

Pfizer

  • Stock

EUR

Last Close

27.04

08/11 21:00

Market Cap

160.65B

Beta: 0.59

Volume Today

53.55M

Avg: 31.28K

PE Ratio

14.41

PFCF: 18.47

Dividend Yield

6.17%

Payout:87.54%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
6.61B
-
5.91B
10.58%
6.59B
11.39%
7.15B
8.50%
7.18B
0.45%
7.54B
5.05%
7.90B
4.67%
8.16B
3.41%
8.55B
4.75%
9.02B
5.47%
9.59B
6.26%
average payables
3.75B
-
3.34B
10.99%
3.53B
5.78%
4.08B
15.52%
4.60B
12.70%
4.67B
1.50%
4.45B
4.67%
4.26B
4.10%
4.94B
15.92%
6.19B
25.29%
6.76B
9.14%
average receivables
15.47B
-
9.01B
41.72%
9.75B
8.22%
11.05B
13.31%
11.27B
1.96%
11.34B
0.59%
11.73B
3.52%
11.63B
0.87%
13.47B
15.81%
15.14B
12.38%
12.85B
15.09%
book value per share
11.20
-
11.24
0.32%
10.48
6.73%
9.78
6.68%
11.94
22.14%
10.80
9.60%
11.34
5.00%
11.38
0.40%
13.78
21.08%
17.06
23.76%
15.59
8.59%
capex per share
-0.22
-
-0.25
16.01%
-0.24
2.89%
-0.33
35.53%
-0.37
13.12%
-0.37
0.71%
-0.47
24.55%
-0.50
7.87%
-0.48
3.66%
-0.58
19.22%
-0.68
18.60%
capex to depreciation
-0.23
-
-0.29
25.09%
-0.29
1.47%
-0.35
19.70%
-0.35
1.85%
-0.34
2.73%
-0.43
25.47%
-0.58
35.37%
-0.52
10.61%
-0.64
22.36%
-0.62
2.80%
capex to operating cash flow
-0.08
-
-0.09
13.70%
-0.10
9.94%
-0.13
21.95%
-0.13
7.07%
-0.14
3.08%
-0.21
48.52%
-0.19
5.96%
-0.08
57.06%
-0.11
32.88%
-0.45
306.16%
capex to revenue
-0.03
-
-0.03
12.37%
-0.03
4.04%
-0.04
23.57%
-0.04
11.49%
-0.04
2.98%
-0.05
22.45%
-0.07
32.86%
-0.03
49.92%
-0.03
3.29%
-0.07
107.08%
cash per share
4.76
-
5.69
19.66%
3.77
33.75%
2.93
22.26%
3.35
14.23%
3.21
4.23%
1.77
44.96%
2.20
24.64%
5.55
152.14%
4.05
26.93%
2.22
45.16%
days of inventory on hand
234.78
-
215.83
8.07%
284.23
31.69%
200.81
29.35%
246.08
22.54%
243.64
0.99%
295.85
21.43%
337.87
14.20%
107.28
68.25%
95.45
11.03%
149.03
56.14%
days payables outstanding
123.14
-
131.11
6.47%
136.95
4.46%
134.29
1.94%
151.20
12.59%
151.67
0.32%
150.73
0.62%
180.95
20.05%
66.06
63.49%
72.36
9.55%
98.15
35.63%
days sales outstanding
66.21
-
63.79
3.66%
80.98
26.95%
77.85
3.87%
78.29
0.57%
77.56
0.94%
85.12
9.75%
97.49
14.54%
70.70
27.48%
52.86
25.24%
69.74
31.95%
debt to assets
0.21
-
0.22
2.21%
0.23
7.41%
0.25
5.36%
0.25
1.13%
0.26
4.37%
0.31
20.28%
0.25
20.29%
0.20
17.85%
0.18
13.27%
0.32
79.50%
debt to equity
0.48
-
0.51
7.59%
0.60
17.06%
0.71
17.36%
0.60
15.47%
0.65
8.92%
0.83
26.89%
0.61
26.71%
0.48
20.82%
0.36
23.94%
0.81
121.55%
dividend yield
0.03
-
0.04
6.04%
0.04
4.09%
0.04
6.28%
0.04
4.24%
0.03
12.13%
0.04
18.43%
0.04
6.23%
0.03
36.06%
0.03
18.45%
0.06
79.97%
earnings yield
0.11
-
0.05
56.17%
0.04
24.47%
0.04
4.50%
0.10
170.18%
0.05
55.84%
0.08
71.39%
0.03
56.33%
0.07
93.57%
0.11
64.29%
0.01
88.19%
enterprise value
232.29B
-
220.86B
4.92%
224.51B
1.65%
227.15B
1.18%
246.39B
8.47%
283.29B
14.97%
257.84B
8.98%
240.97B
6.54%
365.79B
51.80%
321.81B
12.02%
233.40B
27.47%
enterprise value over ebitda
10.59
-
11.48
8.40%
12.69
10.49%
11.91
6.16%
12.18
2.25%
13.23
8.66%
13.06
1.31%
17.13
31.20%
12.82
25.17%
7.37
42.48%
107.46
1,357.18%
ev to operating cash flow
13.08
-
13.08
0.05%
15.47
18.26%
14.29
7.66%
14.96
4.72%
17.90
19.64%
20.48
14.44%
16.73
18.32%
11.23
32.89%
11.00
2.07%
26.83
143.98%
ev to sales
4.50
-
4.45
1.13%
4.60
3.22%
4.30
6.43%
4.69
9.04%
5.28
12.61%
4.98
5.65%
5.75
15.41%
4.50
21.74%
3.21
28.72%
3.99
24.40%
free cash flow per share
2.39
-
2.41
0.77%
2.11
12.59%
2.28
8.33%
2.39
4.57%
2.32
2.77%
1.79
22.69%
2.09
16.48%
5.33
155.11%
4.64
12.96%
0.84
81.91%
free cash flow yield
0.08
-
0.08
0.90%
0.07
15.67%
0.07
7.67%
0.07
6.20%
0.06
19.32%
0.05
13.87%
0.06
17.62%
0.09
59.03%
0.09
0.31%
0.03
67.81%
graham net net
-7.78
-
-8.23
5.79%
-10.89
32.46%
-13.48
23.73%
-11.37
15.62%
-10.99
3.39%
-14.55
32.39%
-11.90
18.19%
-10.11
15.09%
-11.26
11.45%
-19.45
72.68%
graham number
28.53
-
19.08
33.13%
16.30
14.55%
16.15
0.95%
30.97
91.81%
21.48
30.64%
27.30
27.10%
17.99
34.10%
34.89
93.90%
46.34
32.83%
11.41
75.37%
income quality
0.80
-
1.84
128.80%
2.08
12.80%
2.19
5.64%
0.77
64.85%
1.41
83.42%
0.77
45.42%
2.05
165.67%
1.45
29.29%
0.93
35.75%
4.11
340.51%
intangibles to total assets
0.48
-
0.46
4.12%
0.53
15.96%
0.62
17.95%
0.61
2.35%
0.56
8.78%
0.56
0.98%
0.51
9.85%
0.41
19.04%
0.48
17.26%
0.59
21.93%
interest coverage
11.57
-
9.93
14.24%
10.82
9.03%
11.58
6.97%
11.11
4.05%
11.43
2.92%
9.62
15.88%
7.34
23.72%
19.24
162.20%
32.33
68.10%
interest debt per share
5.56
-
5.99
7.75%
6.51
8.52%
7.11
9.24%
7.35
3.42%
7.25
1.33%
9.65
33.02%
7.15
25.87%
6.84
4.40%
6.44
5.81%
12.59
95.57%
inventory turnover
1.55
-
1.69
8.78%
1.28
24.07%
1.82
41.54%
1.48
18.40%
1.50
1.00%
1.23
17.65%
1.08
12.44%
3.40
214.94%
3.82
12.40%
2.45
35.96%
invested capital
0.48
-
0.51
7.59%
0.60
17.06%
0.71
17.36%
0.60
15.47%
0.65
8.92%
0.83
26.89%
0.61
26.71%
0.48
20.82%
0.36
23.94%
0.81
121.55%
market cap
197.99B
-
187.52B
5.28%
189.17B
0.88%
187.66B
0.80%
205.13B
9.31%
243.16B
18.54%
207.00B
14.87%
204.48B
1.22%
330.74B
61.75%
287.35B
13.12%
164.36B
42.80%
net current asset value
-39.24B
-
-39.95B
1.82%
-58.66B
46.83%
-72.83B
24.15%
-59B
18.98%
-45.74B
22.48%
-71.24B
55.75%
-55.69B
21.83%
-44.32B
20.41%
-50.03B
12.88%
-93.88B
87.65%
net debt to ebitda
1.56
-
1.73
10.80%
2.00
15.21%
2.07
3.65%
2.04
1.50%
1.87
8.09%
2.57
37.38%
2.59
0.76%
1.23
52.64%
0.79
35.73%
31.78
3,925.73%
net income per share
3.23
-
1.44
55.43%
1.13
21.71%
1.18
5.14%
3.57
201.22%
1.90
46.78%
2.92
53.85%
1.26
56.75%
3.92
210.52%
5.59
42.56%
0.37
93.37%
operating cash flow per share
2.61
-
2.66
2.03%
2.35
11.68%
2.61
11.14%
2.76
5.64%
2.70
2.30%
2.26
16.14%
2.59
14.71%
5.82
124.35%
5.22
10.28%
1.52
70.80%
payables turnover
2.96
-
2.78
6.08%
2.67
4.27%
2.72
1.98%
2.41
11.18%
2.41
0.31%
2.42
0.63%
2.02
16.70%
5.53
173.92%
5.04
8.72%
3.72
26.27%
receivables turnover
5.51
-
5.72
3.80%
4.51
21.23%
4.69
4.02%
4.66
0.57%
4.71
0.95%
4.29
8.88%
3.74
12.70%
5.16
37.90%
6.91
33.76%
5.23
24.21%
research and ddevelopement to revenue
0.13
-
0.17
30.70%
0.16
6.96%
0.15
5.33%
0.15
2.22%
0.15
2.41%
0.17
12.00%
0.22
34.26%
0.17
24.19%
0.11
33.05%
0.18
60.27%
return on tangible assets
0.24
-
0.10
59.31%
0.09
11.08%
0.11
26.71%
0.32
183.94%
0.16
50.39%
0.22
40.61%
0.09
58.40%
0.21
122.65%
0.31
49.23%
0.02
92.62%
revenue per share
7.57
-
7.82
3.24%
7.91
1.19%
8.68
9.68%
8.80
1.46%
9.14
3.80%
9.29
1.71%
7.54
18.81%
14.51
92.37%
17.89
23.27%
10.25
42.73%
roe
0.29
-
0.13
55.57%
0.11
16.06%
0.12
12.68%
0.30
146.61%
0.18
41.14%
0.26
46.52%
0.11
56.93%
0.28
156.46%
0.33
15.19%
0.02
92.74%
roic
0.11
-
0.09
11.58%
0.10
4.52%
0.12
20.11%
0.21
83.79%
0.14
37.09%
0.12
10.49%
0.10
18.98%
0.20
104.88%
0.28
38.03%
0.10
62.75%
sales general and administrative to revenue
shareholders equity per share
11.20
-
11.24
0.32%
10.48
6.73%
9.78
6.68%
11.94
22.14%
10.80
9.60%
11.34
5.00%
11.38
0.40%
13.78
21.08%
17.06
23.76%
15.59
8.59%
stock based compensation to revenue
0.01
-
0.01
16.52%
0.01
15.93%
0.01
4.48%
0.02
22.21%
0.02
10.66%
0.01
21.57%
0.02
30.02%
0.01
19.39%
0.01
40.23%
0.01
3.26%
tangible asset value
-5.28B
-
-5.61B
6.25%
-23.60B
320.41%
-47.26B
100.22%
-33.04B
30.09%
-24.86B
24.74%
-30.58B
22.97%
-14.58B
52.33%
3.11B
121.33%
1.17B
62.30%
-43.40B
3,802.65%
tangible book value per share
-0.78
-
-0.88
14.06%
-3.82
331.99%
-7.76
103.09%
-5.53
28.70%
-4.23
23.48%
-5.49
29.66%
-2.62
52.21%
0.56
121.15%
0.21
62.35%
-7.60
3,737.14%
working capital
32.88B
-
36.07B
9.71%
14.40B
60.06%
7.83B
45.62%
10.71B
36.76%
18.07B
68.64%
-4.50B
124.91%
9.15B
303.22%
17.02B
86.09%
9.12B
46.42%
-4.46B
148.91%

All numbers in EUR (except ratios and percentages)